Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 10437914)

1.

Cyclin D1 expression in Bowen's disease and cutaneous squamous cell carcinoma.

Shen Y, Xu J, Jin J, Tang H, Liang J.

Mol Clin Oncol. 2014 Jul;2(4):545-548. Epub 2014 Apr 1.

2.

Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development.

Wang X, Sistrunk C, Miliani de Marval PL, Kim Y, Rodriguez-Puebla ML.

Cell Cycle. 2012 Jan 15;11(2):335-42. doi: 10.4161/cc.11.2.18774. Epub 2012 Jan 15.

3.

Developmental stage determines estrogen receptor alpha expression and non-genomic mechanisms that control IGF-1 signaling and mammary proliferation in mice.

Tian J, Berton TR, Shirley SH, Lambertz I, Gimenez-Conti IB, DiGiovanni J, Korach KS, Conti CJ, Fuchs-Young R.

J Clin Invest. 2012 Jan;122(1):192-204. doi: 10.1172/JCI42204. Epub 2011 Dec 19.

4.

Selective anticancer activity of a hexapeptide with sequence homology to a non-kinase domain of Cyclin Dependent Kinase 4.

Warenius HM, Kilburn JD, Essex JW, Maurer RI, Blaydes JP, Agarwala U, Seabra LA.

Mol Cancer. 2011 Jun 13;10:72. doi: 10.1186/1476-4598-10-72.

5.

Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis.

Wang X, Sistrunk C, Rodriguez-Puebla ML.

Am J Pathol. 2011 Jan;178(1):345-54. doi: 10.1016/j.ajpath.2010.11.032. Epub 2010 Dec 23.

6.

Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis.

Patil MA, Lee SA, Macias E, Lam ET, Xu C, Jones KD, Ho C, Rodriguez-Puebla M, Chen X.

Cancer Res. 2009 Jan 1;69(1):253-61. doi: 10.1158/0008-5472.CAN-08-2514.

7.

Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).

Rojas P, Benavides F, Blando J, Perez C, Cardenas K, Richie E, Knudsen ES, Johnson DG, Senderowicz AM, Rodriguez-Puebla ML, Conti CJ.

Mol Carcinog. 2009 Jun;48(6):508-16. doi: 10.1002/mc.20489.

8.

Enhanced malignant tumorigenesis in Cdk4 transgenic mice.

Miliani de Marval PL, Macias E, Conti CJ, Rodriguez-Puebla ML.

Oncogene. 2004 Mar 11;23(10):1863-73.

9.

Differential expression of cyclin D1 in the human hair follicle.

Xu X, Lyle S, Liu Y, Solky B, Cotsarelis G.

Am J Pathol. 2003 Sep;163(3):969-78.

10.

Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis.

Xia X, Qian S, Soriano S, Wu Y, Fletcher AM, Wang XJ, Koo EH, Wu X, Zheng H.

Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10863-8. Epub 2001 Aug 21.

11.

Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis.

Miliani de Marval PL, Gimenez-Conti IB, LaCava M, Martinez LA, Conti CJ, Rodriguez-Puebla ML.

Am J Pathol. 2001 Jul;159(1):369-79.

12.

Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia.

Rodriguez-Puebla ML, LaCava M, Miliani De Marval PL, Jorcano JL, Richie ER, Conti CJ.

Am J Pathol. 2000 Sep;157(3):1039-50.

13.

The Drosophila cyclin D-Cdk4 complex promotes cellular growth.

Datar SA, Jacobs HW, de la Cruz AF, Lehner CF, Edgar BA.

EMBO J. 2000 Sep 1;19(17):4543-54.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk